通信販売業務停止命令 against 株式会社オルリンクス製薬

株式会社オルリンクス製薬 (Specified Commercial Transactions Act)
Specified Commercial Transactions ActConsumer Affairs AgencyConfirmed entity match10 April 2024
For developers: integration details

You do not need this for normal browsing. Use it when integrating this enforcement record into an internal tool or AI workflow.

/api/v1/enforcements?corporate_number=6180001133049&limit=10

Action summary

Company
Original: 株式会社オルリンクス製薬
Corporate Number: 6180001133049
Entity match
Confirmed entity match95/100Machine extracted
Normalized Japanese name matched to a company profile with Corporate Number
Matched by normalized Japanese company name to an enriched company profile with a Corporate Number.
Governing law
Specified Commercial Transactions Act
特定商取引法
Action type
通信販売業務停止命令
通信販売業務停止命令
Action date
10 April 2024
Issuing authority
Consumer Affairs Agency
消費者庁

Violation

Machine-translated summary — verify against original

From April 10, 2024, to July 9, 2024, the Consumer Affairs Agency ordered the suspension of part of the mail-order business operations (advertising, application acceptance, and contract conclusion) of Orlinkus Pharmaceutical Co., Ltd.

Show original Japanese text

令和6年4月10日から令和6年7月9日までの3か月間、通信販売に関する業務の一部(広告、申込受付及び契約締結)を停止するよう命じました。

Compliance context

Context needed

This is a public Japanese regulatory disclosure. The exact legal effect depends on the cited source and regulator.

Consumer transaction law covering specified sales channels such as mail order, door-to-door sales, telemarketing, and related practices.

Review the original Japanese source and determine relevance to your counterparty-risk workflow.

This context is an operational aid for review workflows, not a credit opinion or legal conclusion.

Evidence pack

Original Consumer Affairs Agency announcement (Japanese)Archived source snapshot
Extracted at
2026-04-24T23:22:31.486+00:00
Evidence checked
2026-04-24T23:22:31.486+00:00
Archive captured
2026-04-06T06:30:56.12+00:00
Show audit JSON
{
  "record": {
    "id": "cbd132ed-dbc8-496b-8622-25645c0a241c",
    "url": "https://regbase.jp/en/enforcement/tokushoho-orurinkusuzhi-yao-20240410",
    "company_name_original": "株式会社オルリンクス製薬",
    "company_name_registry": "株式会社オルリンクス製薬",
    "corporate_number": "6180001133049",
    "law": {
      "ja": "特定商取引法",
      "en": "Specified Commercial Transactions Act"
    },
    "action_type": {
      "ja": "通信販売業務停止命令",
      "en": "通信販売業務停止命令"
    },
    "authority": {
      "ja": "消費者庁",
      "en": "Consumer Affairs Agency"
    }
  },
  "entity_match": {
    "status": "confirmed",
    "confidence": 95,
    "method": "normalized_name_with_corporate_number",
    "method_label": "Normalized Japanese name matched to a company profile with Corporate Number",
    "notes": "Matched by normalized Japanese company name to an enriched company profile with a Corporate Number."
  },
  "review": {
    "status": "unreviewed",
    "label": "Machine extracted"
  },
  "compliance_context": {
    "severity": "Context needed",
    "actionMeaning": "This is a public Japanese regulatory disclosure. The exact legal effect depends on the cited source and regulator.",
    "practicalNote": "Review the original Japanese source and determine relevance to your counterparty-risk workflow.",
    "lawContext": "Consumer transaction law covering specified sales channels such as mail order, door-to-door sales, telemarketing, and related practices."
  },
  "evidence": {
    "recordUrl": "https://regbase.jp/en/enforcement/tokushoho-orurinkusuzhi-yao-20240410",
    "officialSourceUrl": "https://www.caa.go.jp/notice/entry/037336/",
    "archiveUrl": "https://kiroku.today/view/e3fa3a032emtag5f",
    "archiveCapturedAt": "2026-04-06T06:30:56.12+00:00",
    "extractedAt": "2026-04-24T23:22:31.486+00:00",
    "translatedAt": "2026-05-01T06:40:36.631+00:00",
    "evidenceCheckedAt": "2026-04-24T23:22:31.486+00:00",
    "generatedAt": "2026-05-20T04:57:58.493Z"
  },
  "limitations": [
    "RegBase aggregates public Japanese government disclosures and does not provide a credit opinion.",
    "English summaries are provided for reference. The original Japanese source is authoritative.",
    "Possible or unresolved entity matches should be manually verified before use in a decision."
  ]
}

The original Japanese disclosure is the authoritative record. Use possible or unresolved matches only as leads for manual review.

Company info

English name
株式会社オルリンクス製薬 Japanese original
Japanese name
株式会社オルリンクス製薬
Corporate Number
6180001133049
Registered address
愛知県名古屋市中区丸の内3丁目18番22号
See company profile →

About this recordAggregated and translated from public Japanese government disclosures. The English text is for reference only — authoritative content is the linked Japanese source.